Alexandra Santos
About Alexandra Santos
Alexandra Santos is a Senior Medical Manager specializing in Cell Therapy at Kite Pharma in Portugal, where she has worked since 2021. She has extensive experience in pharmacovigilance and medical affairs, having held various roles at Gilead Sciences over a span of several years.
Work at Kite Pharma
Alexandra Santos has been employed at Kite Pharma as a Senior Medical Manager in Cell Therapy since 2021. In this role, she is responsible for overseeing medical strategies and ensuring compliance with regulatory standards within the cell therapy division. Her tenure at Kite Pharma has contributed to the company's focus on innovative treatment solutions in the field of oncology.
Previous Experience at Gilead Sciences
Prior to her current role at Kite Pharma, Alexandra Santos held several positions at Gilead Sciences. She served as a Senior Safety Specialist for 10 months in 2013, followed by various roles in pharmacovigilance and medical affairs from 2014 to 2020. These positions included Associate Manager of Drug Safety & Public Health, Manager of Pharmacovigilance & Epidemiology, and Senior Manager of Pharmacovigilance & Epidemiology. Her experience at Gilead Sciences provided her with extensive knowledge in drug safety and regulatory compliance.
Educational Background in Pharmacy
Alexandra Santos earned her Master's degree in Pharmacy from Faculdade de Farmacia Universidade de Lisboa, completing her studies from 2001 to 2007. Additionally, she pursued a postgraduate degree in Regulatory Affairs, focusing on the regulation and evaluation of medicines and health products, from 2010 to 2011. This educational foundation has equipped her with the necessary skills for her roles in the pharmaceutical industry.
Career at Schering-Plough
Before her extensive career at Gilead Sciences, Alexandra Santos worked at Schering-Plough as a Quality Assurance professional for one year from 2007 to 2008. This early experience in quality assurance contributed to her understanding of compliance and regulatory standards in the pharmaceutical sector.